Hologic (HOLX) volatility increases into Q1 and outlook
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 9/22/2026
- Nasdaq hits intraday record high on tech boost, Mideast negotiation hopes
- Exclusive: SB Energy Nasdaq IPO moving forward as planned
- AI and earnings keep driving markets as focus shifts to Trump-Xi summit
- Meta bull case increasingly playing out, Mizuho says
- Oil prices rise on Trump timeline for Iran peace deal: after US elections
- Pennsylvania measles cases near 800 as outbreak grows
- A timeline of Trump administration moves to weaken endangered species protections
- Meta AI agent ‘Muse’ triggers massive tech rally as chips and Wall Street soar
- Nasdaq notches record-high close, AI optimism reignites and Treasury yields retreat
- SpaceX and Tesla’s AI linkup is getting deeper. Here’s what Morgan Stanley sees
Hologic (HOLX) PT Lowered to $48 at Canaccord Genuity Following 1Q Results
February 12, 2018 7:54 AM ESTCanaccord Genuity lowered its price target on Hologic (NASDAQ: HOLX) to $48.00 (from $50.00) while maintaining a Buy rating following the company's 1Q results. Revenues of ~$791M beat the Street's $786M, and adjusted EPS of $0.55 beat the Street's $0.50.
HOLX reiterated its prior FY'18... More
